|
    ENTX U.S.: Nasdaq

    Entera Bio Ltd.

    ENTXUS
    After Hours
    Back To Top
    Last Updated: Jul 30, 2021 5:55 p.m. EDT Delayed quote

    $ 5.21

    0.07 1.36%
    After Hours Volume: 382
    Close Chg Chg %
    $5.14 0.05 0.98%
    Advanced Charting
    • $
    • %
    • Vol
    Volume: 236.99K 65 Day Avg: 3.11M
    8% vs Avg
    4.92 Day Range 5.15
    1.00 52 Week Range 10.16

    Your Watchlists

    Customize eLesor

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    ENTX Overview

    Performance

    5 Day
    • -3.20%
    1 Month
    • -17.10%
    3 Month
    • 53.43%
    YTD
    • 375.93%
    1 Year
    • 204.14%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 3 Full Ratings

    Recent News

    • eLesor
    • Dow Jones

    Entera Bio Shares Jump 50% After Positive Results for Osteoporosis Treatment

    Entera Bio Sees Positive Results From Trial for Osteoporosis Treatment

    Entera Bio stock price target raised to $10 from $5 at Maxim Group

    Entera shares jump 11.5% on news of collaboration with Amgen

    Entera Bio sets IPO terms; to offer 5 million shares priced at $10 to $12 each

    Entera Bio sets IPO terms; to offer 5 mln shares priced at $10 to $12 each

    • Other News
    • Press Releases

    Entera Bio Stock Could More Than Double From Here, Says Analyst

    on TipRanks.com

    Entera (ENTX) Up on Positive Results From Osteoporosis Drug

    on Zacks.com

    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

    on InvestorPlace.com

    Entera Bio Surging on Drug Development; Will the Rise Continue?

    on TipRanks.com

    ENTX Stock: The Huge FDA News Sending Entera Bio Soaring

    on InvestorPlace.com

    4 Stocks to Boost Your Portfolio (In an Unintuitive Way)

    on InvestorPlace.com

    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

    on InvestorPlace.com

    Entera Bio (ENTX) is Overbought: Is A Drop Coming?

    on Zacks.com

    B.Riley Financial Initiates a Buy Rating on Entera Bio (ENTX)

    on SmarterAnalyst

    Here's Why Entera Bio (ENTX) Stock Has Almost Tripled This Year

    on Zacks.com

    The Zacks Analyst Blog Highlights: BioNTech, Ocugen, Rubius Therapeutics and Entera Bio

    on Zacks.com

    4 Biotech Stocks That Have Already Doubled This Year So Far

    on Zacks.com

    Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Wednesday Morning

    on InvestorPlace.com

    Halted Stocks: What to Know as ENTX Stock Faces Trading Halts

    on InvestorPlace.com

    ENTX Stock: 11 Things for Entera Bio Investors to Know as Shares Blast 200%+ Higher

    on InvestorPlace.com

    Analysts Are Bullish on These Healthcare Stocks: Entera Bio (ENTX), Stryker (SYK)

    on SmarterAnalyst

    Entera Bio Ltd.

    Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which focuses on the development and commercialization of orally delivered large molecule therapeutics. It develops an oral formulation of parathyroid hormone. The company was founded on June 1, 2010 and is headquartered in Jerusalem, Israel.